PV Clinical Trial Project Award

Regulis are pleased to announce the award of a further two PV projects for phase I clinical trials (bioequivalence and QT studies).

Regulis will provide full drug safety services throughout the duration of both studies at trial sites in the US and Germany. Our services shall include provision of the clinical trial safety database, SAE processing and assessment, expedited reporting of all SUSARs, attending safety and tolerability meeting, continuous evaluation of the risk-benefit profile of the study and contributing to the final study report.